Roger Mclendon
Roger Mclendon
Verifierad e-postadress på duke.edu - Startsida
Titel
Citeras av
Citeras av
År
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
S Bao, Q Wu, RE McLendon, Y Hao, Q Shi, AB Hjelmeland, MW Dewhirst, ...
nature 444 (7120), 756-760, 2006
58592006
An integrated genomic analysis of human glioblastoma multiforme
DW Parsons, S Jones, X Zhang, JCH Lin, RJ Leary, P Angenendt, ...
science 321 (5897), 1807-1812, 2008
54002008
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network
Nature 455 (7216), 1061, 2008
53452008
IDH1 and IDH2 Mutations in Gliomas
H Yan, DW Parsons, G Jin, R McLendon, BA Rasheed, W Yuan, I Kos, ...
New England journal of medicine 360 (8), 765-773, 2009
45042009
Stem cell–like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
S Bao, Q Wu, S Sathornsumetee, Y Hao, Z Li, AB Hjelmeland, Q Shi, ...
Cancer research 66 (16), 7843-7848, 2006
13662006
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Z Li, S Bao, Q Wu, H Wang, C Eyler, S Sathornsumetee, Q Shi, Y Cao, ...
Cancer cell 15 (6), 501-513, 2009
11492009
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
10322013
Altered telomeres in tumors with ATRX and DAXX mutations
CM Heaphy, RF De Wilde, Y Jiao, AP Klein, BH Edil, C Shi, C Bettegowda, ...
Science 333 (6041), 425-425, 2011
8212011
Phase II trial of gefitinib in recurrent glioblastoma
JN Rich, DA Reardon, T Peery, JM Dowell, JA Quinn, KL Penne, ...
Journal of Clinical Oncology 22 (1), 133-142, 2004
7862004
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
JM Heddleston, Z Li, RE McLendon, AB Hjelmeland, JN Rich
Cell cycle 8 (20), 3274-3284, 2009
7212009
The genetic landscape of the childhood cancer medulloblastoma
DW Parsons, M Li, X Zhang, S Jones, RJ Leary, JCH Lin, SM Boca, ...
science 331 (6016), 435-439, 2011
6922011
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
JH Sampson, AB Heimberger, GE Archer, KD Aldape, AH Friedman, ...
Journal of clinical oncology 28 (31), 4722, 2010
6882010
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
PA Northcott, DJH Shih, J Peacock, L Garzia, AS Morrissy, T Zichner, ...
Nature 488 (7409), 49-56, 2012
6632012
Integrin alpha 6 regulates glioblastoma stem cells
JD Lathia, J Gallagher, JM Heddleston, J Wang, CE Eyler, J MacSwords, ...
Cell stem cell 6 (5), 421-432, 2010
6152010
Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth
L Cheng, Z Huang, W Zhou, Q Wu, S Donnola, JK Liu, X Fang, AE Sloan, ...
Cell 153 (1), 139-152, 2013
6052013
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
CJ Wikstrand, LP Hale, SK Batra, ML Hill, PA Humphrey, SN Kurpad, ...
Cancer research 55 (14), 3140-3148, 1995
5991995
A public database for gene expression in human cancers
A Lal, AE Lash, SF Altschul, V Velculescu, L Zhang, RE McLendon, ...
Cancer research 59 (21), 5403-5407, 1999
5451999
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Y Jiao, PJ Killela, ZJ Reitman, BA Rasheed, CM Heaphy, RF de Wilde, ...
Oncotarget 3 (7), 709, 2012
5302012
Mutations in CIC and FUBP1 contribute to human oligodendroglioma
C Bettegowda, N Agrawal, Y Jiao, M Sausen, LD Wood, RH Hruban, ...
Science 333 (6048), 1453-1455, 2011
4932011
PTEN gene mutations are seen in high-grade but not in low-grade gliomas
BKA Rasheed, TT Stenzel, RE McLendon, R Parsons, AH Friedman, ...
Cancer research 57 (19), 4187-4190, 1997
4931997
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20